The latest technology and medical devices driving innovation in pharma and health.
TECH COMMENTATOR >
David Reilly
David Reilly is Managing Director of Let's Learn Digital, educating and inspiring business in digital and emerging technologies.
Is technology in vascular care the key to more responsive treatment?
In the midst of a once-in-a-generation public health crisis,...
Virtual reality and the possibilities for pharma
Virtual Reality (VR) has occupied the fringes of pharma...
Machine learning biotech firm agrees deal to develop new cancer treatments
An Oxford-based biotech company that uses machine learning to identify and predict the effectiveness of future immune therapies, has agreed a partnership with Norwegian...
- Advertisement -
- Advertisement - 
- Advertisement - 
AI stroke diagnostic software framework now available to the NHS
NHS Shared Business Services (NHS SBS) has unveiled The Provision of AI Software in Neuroscience for Stroke Decision Making Support procurement framework agreement, the...
Vaccine passports, technology and trust: is the NHS heading in the right direction?
"The NHS should concentrate its resource on clinical settings and clinical outcomes and rely on technology companies to bring in existing and viable innovations"
ZS and IgniteData partner to transform patient data automation for clinical trails
ZS has entered into a strategic partnership through a supporting multimillion dollar investment in...
NICE commits to greater flexibility in its evaluation of new health technologies
The National Institute for Health and Care Excellence (NICE) is changing the way it...
Predictions for pharma in 2022
Pauls Simms’ annual predictions, co-hosted this year with Jessica DaMassa and delivered as a...
